Suppr超能文献

相似文献

2
Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma.
Free Radic Biol Med. 2017 Nov;112:597-607. doi: 10.1016/j.freeradbiomed.2017.09.002. Epub 2017 Sep 8.
3
Effects of low-density lipoprotein docosahexaenoic acid nanoparticles on cancer stem cells isolated from human hepatoma cell lines.
Mol Biol Rep. 2018 Oct;45(5):1023-1036. doi: 10.1007/s11033-018-4252-2. Epub 2018 Aug 1.
4
Assessing the safety of transarterial locoregional delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat liver.
Eur J Pharm Biopharm. 2021 Jan;158:273-283. doi: 10.1016/j.ejpb.2020.10.018. Epub 2020 Nov 24.
7
Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cells.
Nanomedicine (Lond). 2014 Jul;9(14):2123-41. doi: 10.2217/nnm.13.187. Epub 2014 Jan 7.
9
Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
Gastroenterology. 2018 Mar;154(4):1024-1036.e9. doi: 10.1053/j.gastro.2017.10.050. Epub 2018 Jan 31.

引用本文的文献

1
APT imaging of hepatocellular carcinoma signals an effective therapeutic response in advance of tumor shrinkage.
Hepat Oncol. 2024 Dec 31;11(1):2389031. doi: 10.1080/20450923.2024.2389031. Epub 2024 Sep 12.
3
Ferroptosis targeting natural compounds as a promising approach for developing potent liver cancer agents.
Front Pharmacol. 2024 Apr 26;15:1399677. doi: 10.3389/fphar.2024.1399677. eCollection 2024.
4
Ethnopharmacological uses of fauna among the people of central Punjab, Pakistan.
Front Vet Sci. 2024 Apr 12;11:1351693. doi: 10.3389/fvets.2024.1351693. eCollection 2024.
5
Marine biomaterials in biomedical nano/micro-systems.
J Nanobiotechnology. 2023 Nov 5;21(1):408. doi: 10.1186/s12951-023-02112-w.
6
Low-density lipoprotein: a versatile nanoscale platform for targeted delivery.
Nanoscale Adv. 2023 Jan 24;5(4):1011-1022. doi: 10.1039/d2na00883a. eCollection 2023 Feb 14.
7
Recent Development of LDL-Based Nanoparticles for Cancer Therapy.
Pharmaceuticals (Basel). 2022 Dec 23;16(1):18. doi: 10.3390/ph16010018.
10
Enhanced oral bioavailability and antitumor therapeutic efficacy of sorafenib administered in core-shell protein nanoparticle.
Drug Deliv Transl Res. 2022 Nov;12(11):2824-2837. doi: 10.1007/s13346-022-01142-5. Epub 2022 Jun 9.

本文引用的文献

1
Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal.
Oxid Med Cell Longev. 2014;2014:360438. doi: 10.1155/2014/360438. Epub 2014 May 8.
2
Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cells.
Nanomedicine (Lond). 2014 Jul;9(14):2123-41. doi: 10.2217/nnm.13.187. Epub 2014 Jan 7.
3
15-lipoxygenase metabolites of docosahexaenoic acid inhibit prostate cancer cell proliferation and survival.
PLoS One. 2012;7(9):e45480. doi: 10.1371/journal.pone.0045480. Epub 2012 Sep 20.
4
Epidemiology of viral hepatitis and hepatocellular carcinoma.
Gastroenterology. 2012 May;142(6):1264-1273.e1. doi: 10.1053/j.gastro.2011.12.061.
5
Consumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma.
Gastroenterology. 2012 Jun;142(7):1468-75. doi: 10.1053/j.gastro.2012.02.018. Epub 2012 Feb 16.
6
Hepatocellular carcinoma.
N Engl J Med. 2011 Sep 22;365(12):1118-27. doi: 10.1056/NEJMra1001683.
7
Complications of hepatic chemoembolization.
Semin Intervent Radiol. 2006 Jun;23(2):119-25. doi: 10.1055/s-2006-941442.
8
Chemistry and biochemistry of lipid peroxidation products.
Free Radic Res. 2010 Oct;44(10):1098-124. doi: 10.3109/10715762.2010.498477.
10
Trans-4-hydroxy-2-hexenal, a product of n-3 fatty acid peroxidation: make some room HNE..
Free Radic Biol Med. 2010 Jul 1;49(1):1-8. doi: 10.1016/j.freeradbiomed.2010.03.015. Epub 2010 Mar 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验